Xiangjun Zhou

This researcher's work centers on kidney disease, particularly how kidney stones (calcium oxalate crystals) and acute kidney injury cause tissue damage, fibrosis (scarring), and cell death through processes like ferroptosis (an iron-dependent form of cell death). A separate cluster of recent publications examines psychiatric and neurological topics, including antidepressant treatment outcomes, schizophrenia risk, depression-related brain volume changes, and stroke rehabilitation. The lab uses molecular and genetic approaches, often studying specific proteins and signaling pathways (e.g., HIF-1α, GPX4, BMAL1, EZH2) in animal or cell models.

Publication output has grown over the past decade, rising from roughly 4-5 papers per year in the late 2010s to a peak of 12 in 2023 and 11 in 2025, though with a notable dip to 3 in 2024.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026